News
Despite the FDA commissioner’s promises of partnership and collaboration, personnel changes and continued federal cuts create ...
Bain and Kohlberg are leading an investment round in PCI Pharma Services, valuing it at $10 billion, as AI accelerates drug ...
Shares U.S. Healthcare ETF tracks the performance of the Russell 1000 Health Care RIC 22.5/45 Capped Gross Index. Click here ...
The firms lead an investment valuing PCI Pharma at $10 billion, see the company benefiting from broader trends.
A new fight is brewing over the Medicare drug price negotiation program after the Trump administration proposed to consider ...
Opinion
GLP-1s, Personalization, and Big Pharma Power Plays: What’s Really at Stake in the Eli Lilly LawsuitThis lawsuit may look like a business dispute on the surface. But underneath, it’s about something much more important: the right of patients to receive personalized, affordable care.
FHLC is a solid healthcare ETF, but VHT offers slightly better performance, liquidity, and diversification for a similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results